1-4 of 4
Jose I Sangerman, PhD
Close
Sort by
Journal Articles

Multiple Oral Therapeutics Suppress Repressors (LSD-1, HDACs, and BCL11A) of Gamma Globin Gene Expression

Yan Dai, PhD, Douglas V Faller, MD PhD, Jose I Sangerman, PhD, Suthat Fucharoen, Susan P Perrine, MD
Journal: Blood
Blood (2014) 124 (21): 2687.
https://doi.org/10.1182/blood.V124.21.2687.2687
Published: 2014
Journal Articles

Next Generation Clinical-Stage HbF Inducers Exhibit Multiple Molecular Actions In Vitro and In Vivo and Offer Personalized Therapeutic Regimens

Betty S. Pace, MD, Jose I Sangerman, PhD, Michael S Boosalis, PhD, Roman Wolf, DVM, Yan Dai, PhD, David H.K. Chui, MD, Levi Makala, PhD, DVM, Biadru Li, PhD, Douglas V Faller, MD, PhD, Susan P Perrine, MD
Journal: Blood
Blood (2013) 122 (21): 560.
https://doi.org/10.1182/blood.V122.21.560.560
Published: 2013
Journal Articles

An Approach for Tailoring Diverse Therapeutic Inducers of Fetal Globin to Genetic Modifier Profiles,

Susan P Perrine, MD, David H.K. Chui, MD, Jose I Sangerman, PhD, Michael S Boosalis, PhD, Douglas V Faller, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3188.
https://doi.org/10.1182/blood.V118.21.3188.3188
Published: 2011
Journal Articles

Identification of New and Diverse Inducers of Fetal Hemoglobin with High Throughput Screening (HTS)

Jose I Sangerman, PhD, Michael S Boosalis, PhD, Ling Shen, MD, Sarah Haigh, PhD, Ada Kane, Gary L White, DVM, MMS, Susan P Perrine, MD, Douglas V Faller, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4277.
https://doi.org/10.1182/blood.V116.21.4277.4277
Published: 2010